Controlled release of proteins from pluronic-based nano-carrier

[1]  Yongfeng Zhou,et al.  Self‐Assembly of Hyperbranched Polymers and Its Biomedical Applications , 2010, Advanced materials.

[2]  W. Sebald,et al.  Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues. , 2010, Bioconjugate chemistry.

[3]  Young Ha Kim,et al.  In-vivo tumor targeting of pluronic-based nano-carriers. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Jeong-Ok Lim,et al.  Controlled release of BMP-2 from alginate nanohydrogels enhanced osteogenic differentiation of human bone marrow stromal cells , 2010 .

[5]  J. Nah,et al.  Insulin-incorporated chitosan nanoparticles based on polyelectrolyte complex formation , 2010 .

[6]  W. Sebald,et al.  Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery. , 2010, Biomaterials.

[7]  T. Higashi,et al.  Slow-release system of pegylated lysozyme utilizing formation of polypseudorotaxanes with cyclodextrins. , 2009, International journal of pharmaceutics.

[8]  O. Annunziata,et al.  Solubility of lysozyme in the presence of aqueous chloride salts: common-ion effect and its role on solubility and crystal thermodynamics. , 2008, Journal of the American Chemical Society.

[9]  Young Ha Kim,et al.  One pot, single phase synthesis of thermo-sensitive nano-carriers by photo-crosslinking of a diacrylated pluronic , 2008 .

[10]  Young Ha Kim,et al.  Sustained release of human growth hormone from heparin-based hydrogel. , 2008, Biomacromolecules.

[11]  G. Tae,et al.  A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. , 2006, Biomaterials.

[12]  E. Ruckenstein,et al.  Preferential hydration and solubility of proteins in aqueous solutions of polyethylene glycol. , 2006, Biophysical chemistry.

[13]  J. Hubbell,et al.  Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol). , 2005, Biomaterials.

[14]  N. Elvassore,et al.  Nisin-loaded poly-L-lactide nano-particles produced by CO2 anti-solvent precipitation for sustained antimicrobial activity. , 2004, International journal of pharmaceutics.

[15]  R. Emanuele,et al.  Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans. , 2002, Journal of pharmaceutical sciences.

[16]  A. Mikos,et al.  Controlled release of transforming growth factor β1 from biodegradable polymer microparticles , 2000 .

[17]  Q. Ye,et al.  DepoFoam technology: a vehicle for controlled delivery of protein and peptide drugs. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[18]  J. M. Harris,et al.  Novel degradable poly(ethylene glycol) hydrogels for controlled release of protein. , 1998, Journal of pharmaceutical sciences.

[19]  G. Narsimhan,et al.  Thermodynamics of precipitation of globular proteins by nonionic polymers , 1996 .

[20]  L. Claes,et al.  In vitro biocompatibility of bioresorbable polymers: poly(L, DL-lactide) and poly(L-lactide-co-glycolide). , 1996, Biomaterials.

[21]  K. Ingham.  Protein precipitation with polyethylene glycol. , 1984, Methods in enzymology.